Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

Lancet

Volumn 348, Issue 9036, 1996, Pages 1212-1215

  Grellier, L ^a   Mutimer, D ^b   Ahmed, M ^b   Brown, D ^a   Burroughs, A K ^a   Rolles, K ^a   McMaster, P ^b   Beranek, P ^c   Kennedy, F ^b   Kibbler, H ^a   McPhillips, P ^c   Elias, E ^b   Dusheiko, G ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; LAMIVUDINE; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PATIENT; PRIORITY JOURNAL; PROPHYLAXIS; VIRUS REPLICATION;

EID: 16044367618     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)04444-3     Document Type: Article

References (10)

1. Bismuth H. Hepatic transplantation in Europe: improved survival. Eur J Gastroenterol Hepatol 1989; 1: 79-82.
2. O'Grady JG, Smith HM, Davies SE, et al. Hepatitis B virus reinfection after othrotopic liver transplantation: serolological and clinical implications. J Hepatol 1992; 14: 104-11.
3. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842-17.
4. Muller R, Samuel D, Fassati LR, Benhamou J-P, Bismuth H, Alexander GJM. 'EUROHEP' consensus report on the management of liver transplantation for hepatitis B virus infection. J Hepatol 1994; 21: 1140-43.
5. Marcellin P, Samuel D, Areias J, et al. Pretransplantation Interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Hepatology 1994; 19: 6-12.
6. McMillan JS, Shaw T, Angus PW, Locarnini SA. Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro. Hepatology 1995; 22: 36-43.
7. De la Mata M, Montero J, Fraga E, Gonzalez R, Pera C, Mino G. Efficacy of ganciclovir in the treatment of hepatitis B virus infection of the liver graft: long term results. Hepatology 1995; 22: 95A (abstr).
8. Singh N, Gayowski T. Lack of sustained efficacy of combination ganciclovir and foscamet for hepatitis B virus recurrence after liver transplantation. Transplantation 1995; 59: 1629-30.
9. Ogata N, Östberg L, Ehrlich PH, Wong DC, Miller RH, Purcell RH. Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen. Proc Natl Acad Sci USA 1993; 90: 3014-18.
10. Ilan Y, Nagler A, Adler R, et al. Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation. Hepatology 1993; 18: 256-52.